The TPP1-telomerase structures herein presented represent attractive pharmacological targets for drug design of innovative therapeutics in cancer and telomeropathies like Hoyeraal-Hreidarsson syndrome. Here, TPP1 is linked to Hoyeraal-Hreidarsson syndrome.